Circulating endothelial cells as biomarkers in clinical oncology
- 1 May 2010
- journal article
- review article
- Published by Elsevier in Microvascular Research
- Vol. 79 (3) , 224-228
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus BevacizumabClinical Cancer Research, 2009
- Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast CancerJournal of Clinical Oncology, 2008
- Modes of resistance to anti-angiogenic therapyNature Reviews Cancer, 2008
- Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromesLeukemia, 2007
- Id1 Restrains p21 Expression to Control Endothelial Progenitor Cell FormationPLOS ONE, 2007
- Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitorsExperimental Hematology, 2007
- The multifaceted circulating endothelial cell in cancer: towards marker and target identificationNature Reviews Cancer, 2006
- Is nonangiogenesis a novel pathway for cancer progression? A study using 3-dimensional tumour reconstructionsBritish Journal of Cancer, 2006
- Circulating endothelial cellsThrombosis and Haemostasis, 2005
- Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 1997